Phillip A. Romanski, M.D., M.Sc., is board certified in Obstetrics and Gynecology and is board eligible in Reproductive Endocrinology and Infertility. He specializes in reproductive health and infertility as well as reproductive surgery. He serves as the Director of Research for SGF New York.
Dr. Romanski earned his medical degree from the University of Central Florida College of Medicine where he was elected to the prestigious Alpha Omega Alpha Honor Medical Society. He then began his postdoctoral training at Harvard Medical School, Brigham and Women’s Hospital/Massachusetts General Hospital where he completed his residency in Obstetrics and Gynecology. During his time in Boston, he was recognized for his dedication to education and mentorship when he was selected to serve as the Chief Education Resident for the Harvard Medical School Ob/Gyn clerkship.
From there, Dr. Romanski moved to New York City to complete his fellowship in Reproductive Endocrinology and Infertility at the Weill Cornell Medical Center/NewYork-Presbyterian Hospital. There, he not only cultivated extensive expertise in the evaluation and management of female and male infertility, third-party reproduction, and fertility preservation, but also received advanced training in the treatment of mullerian anomalies, infertile patients with a history of unsuccessful treatment, and patients with diminished ovarian reserve.
During his fellowship training, in order to enhance his ability to interpret and conduct clinical research, Dr. Romanski concurrently completed a Master of Science in Clinical and Translational Investigation at the Weill Cornell Graduate School of Medical Sciences. He has authored and contributed to over 50 peer-reviewed publications and written numerous textbook chapters, focusing on topics such as diminished ovarian reserve, age-related infertility, and reproductive surgery, among others. He was also an early leader in researching the association between Covid-19 and infertility treatment outcomes related to mental and physical health and has subsequently been invited to speak to both national and international audiences on this topic. As a distinguished researcher in the field, he is regularly invited to write editorials and review manuscripts for the leading women’s health journals including Fertility and Sterility and Obstetrics & Gynecology.
He serves as a member of the Board of Directors for the Pacific Coast Reproductive Society and is an active contributor to several other professional societies. Recently, he was recognized by the American Society for Reproductive Medicine with a first prize award for his work involving the new mullerian anomaly classification system.
Dr. Romanski provides patient care at SGF New York’s SoHo and Uptown Manhattan locations. In his free time, you can find Dr. Romanski exploring New York City with his wife and cat or training for his next marathon.
Read More
Phillip A. Romanski, M.D., M.Sc., is board certified in Obstetrics and Gynecology and is board eligible in Reproductive Endocrinology and Infertility. He specializes in reproductive health and infertility as well as reproductive surgery. He serves as the Director of Research for SGF New York.
Dr. Romanski earned his medical degree from the University of Central Florida College of Medicine where he was elected to the prestigious Alpha Omega Alpha Honor Medical Society. He then began his postdoctoral training at Harvard Medical School, Brigham and Women’s Hospital/Massachusetts General Hospital where he completed his residency in Obstetrics and Gynecology. During his time in Boston, he was recognized for his dedication to education and mentorship when he was selected to serve as the Chief Education Resident for the Harvard Medical School Ob/Gyn clerkship.
From there, Dr. Romanski moved to New York City to complete his fellowship in Reproductive Endocrinology and Infertility at the Weill Cornell Medical Center/NewYork-Presbyterian Hospital. There, he not only cultivated extensive expertise in the evaluation and management of female and male infertility, third-party reproduction, and fertility preservation, but also received advanced training in the treatment of mullerian anomalies, infertile patients with a history of unsuccessful treatment, and patients with diminished ovarian reserve.
During his fellowship training, in order to enhance his ability to interpret and conduct clinical research, Dr. Romanski concurrently completed a Master of Science in Clinical and Translational Investigation at the Weill Cornell Graduate School of Medical Sciences. He has authored and contributed to over 50 peer-reviewed publications and written numerous textbook chapters, focusing on topics such as diminished ovarian reserve, age-related infertility, and reproductive surgery, among others. He was also an early leader in researching the association between Covid-19 and infertility treatment outcomes related to mental and physical health and has subsequently been invited to speak to both national and international audiences on this topic. As a distinguished researcher in the field, he is regularly invited to write editorials and review manuscripts for the leading women’s health journals including Fertility and Sterility and Obstetrics & Gynecology.
He serves as a member of the Board of Directors for the Pacific Coast Reproductive Society and is an active contributor to several other professional societies. Recently, he was recognized by the American Society for Reproductive Medicine with a first prize award for his work involving the new mullerian anomaly classification system.
Dr. Romanski provides patient care at SGF New York’s SoHo and Uptown Manhattan locations. In his free time, you can find Dr. Romanski exploring New York City with his wife and cat or training for his next marathon.
Read Less
Board Certified 